evidence: Covid: Oxford vaccine shows 'encouraging' immune response in older adults - Published The Oxford coronavirus vaccine shows a strong immune response in adults in their 60s and 70s, raising hopes that it can protect age groups most at risk from the virus. [...] Work began on the vaccine in January and it was developed in under three months, starting human trials - the first in Europe - in April in Oxford.